Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

NCT00740064 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Raltegravir and Abacavir/Lamivudine

Sponsor

Denver Infectious Disease Consultants, PLLC

Collaborators

[object Object]